Bhinneka News Online: Reuters Health Report: March 23, 2017

Thursday, 23 March 2017

Reuters Health Report: March 23, 2017

Click to View in Browser

Thursday, March 23, 2017

Trump fights for healthcare bill, makes headway with conservatives

WASHINGTON (Reuters) - U.S. President Donald Trump and House of Representatives leaders pushed on Wednesday for votes for their plan to overhaul Obamacare and said they were making progress in their efforts to win over conservative Republicans who have demanded changes to the legislation.

GSK and Regeneron to mine gene data from 500,000 Britons

LONDON (Reuters) - Britain's GlaxoSmithKline and U.S.-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed biomedical database, to hunt for new clues linking genes and disease.

Scientists use graphene to power 'electronic skin' that can feel

LONDON (Reuters) - Scientists have found a way to power an experimental kind of electronic skin using solar energy in a further step towards the development of prosthetic limbs or robots with a sense of touch.

Rise of superbug tuberculosis hampers global control efforts

London (Reuters) - Rising rates of superbug tuberculosis (TB) are threatening to derail decades of progress against the contagious disease, experts said on Thursday, and new drugs powerful enough to treat them are few and far between.

U.S. lawmakers seek pricing info on PTC Therapuetics' Duchenne drug

(Reuters) - Two U.S. lawmakers sent a letter on Wednesday to PTC Therapeutics Inc, seeking information about the drugmaker's pricing strategy for its recently acquired muscle-wasting disorder drug.

Mylan recalls 81,000 EpiPens outside U.S. after reports of failure

(Reuters) - Generic drugmaker Mylan NV has recalled about 81,000 EpiPen devices in countries outside the United States, following two reports of the life-saving allergy shot failing to work in emergencies.

Saudi Arabia halts Brazilian beef and poultry imports over food safety fears

DUBAI (Reuters) - Saudi Arabia has stopped beef and poultry imports from four Brazilian companies over concerns about food safety after accusations that individuals had been bribed to allow sales of rotten and salmonella-tainted meats.

Ultragenyx seizure drug fails mid-stage study

(Reuters) - Ultragenyx Pharmaceutical Inc said its drug to treat patients with seizures did not meet the main goal in a mid-stage study, sending its shares down 6.2 percent in after-market trading on Wednesday.

Pregabalin found ineffective against sciatic pain

(Reuters Health) - - Pregabalin, the pain-fighting drug better known by the Pfizer brand name Lyrica, works no better than placebo at relieving the leg pain associated with sciatica, according to results from an Australian study of more than 200 patients.

Scandal-hit Brazil meat plants have not shipped to U.S.: USDA

CHICAGO (Reuters) - No slaughter or processing facilities implicated in Brazil's meat scandal have shipped meat products to the United States, the U.S. Department of Agriculture said on Wednesday.